 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper129th MAINE LEGISLATURE
SECOND REGULAR SESSION-2020
Legislative Document No. 1951
H.P. 1395 House of  Representatives, January 8, 2020
An Act  To Assist Persons with Disabilities Who  Are Subject  to Pill 
Count Requirements
Approved for  introduction by a majority  of the Legislative Council  pursuant to Joint Rule 
203.
Reference to the Committee on Health  and Human Services suggested and  ordered printed.
ROBERT  B. HUNT
Clerk
Presented by Representative MADIGAN of Waterville.
Cosponsored by President  JACKSON  of Aroostook and
Representative: CRAVEN of Lewiston.

Page 1 - 129LR2986(01)-11Be it enacted by the People of the State of Maine as follows:
2Sec. 1.  32 MRSA §2210, sub-§6, as enacted by PL 2017, c. 186, §1, is amended 
3to read:
46.  Opioid medication policy.  No later than January 1, 2018, a A health care entity 
5that includes an individual licensed under this chapter whose scope of practice includes 
6prescribing opioid medication must have in place an opioid medication prescribing policy 
7that applies to all prescribers of opioid medications employed by the entity.  The policy 
8must include, but is not limited to, procedures and practices related to risk assessment, 
9informed consent and counseling on the risk of opioid use.  Procedures established under 
10the policy must provide accommodations for patients with disabilities who are subject to 
11pill count requirements.  For the purposes of this subsection, "health care entity" has the 
12same meaning as in Title 22, section 1718-B, subsection 1, paragraph B.
13Sec. 2.  32 MRSA §2600-C, sub-§6, as enacted by PL 2017, c. 186, §2, is 
14amended to read:
156.  Opioid medication policy.  No later than January 1, 2018, a A health care entity 
16that includes an individual licensed under this chapter whose scope of practice includes 
17prescribing opioid medication must have in place an opioid medication prescribing policy 
18that applies to all prescribers of opioid medications employed by the entity.  The policy 
19must include, but is not limited to, procedures and practices related to risk assessment, 
20informed consent and counseling on the risk of opioid use.  Procedures established under 
21the policy must provide accommodations for patients with disabilities who are subject to 
22pill count requirements.  For the purposes of this subsection, "health care entity" has the 
23same meaning as in Title 22, section 1718-B, subsection 1, paragraph B.
24Sec. 3.  32 MRSA §3300-F, sub-§6, as enacted by PL 2017, c. 186, §3, is 
25amended to read:
266.  Opioid medication policy.  No later than January 1, 2018, a A health care entity 
27that includes an individual licensed under this chapter whose scope of practice includes 
28prescribing opioid medication must have in place an opioid medication prescribing policy 
29that applies to all prescribers of opioid medications employed by the entity.  The policy 
30must include, but is not limited to, procedures and practices related to risk assessment, 
31informed consent and counseling on the risk of opioid use.  Procedures established under 
32the policy must provide accommodations for patients with disabilities who are subject to 
33pill count requirements.  For the purposes of this subsection, "health care entity" has the 
34same meaning as in Title 22, section 1718-B, subsection 1, paragraph B.
35Sec. 4.  32 MRSA §3657, sub-§6, as enacted by PL 2017, c. 186, §4, is amended 
36to read:
376.  Opioid medication policy.  No later than January 1, 2018, a A health care entity 
38that includes an individual licensed under this chapter whose scope of practice includes 
39prescribing opioid medication must have in place an opioid medication prescribing policy 
40that applies to all prescribers of opioid medications employed by the entity.  The policy 
Page 2 - 129LR2986(01)-11must include, but is not limited to, procedures and practices related to risk assessment, 
2informed consent and counseling on the risk of opioid use.  Procedures established under 
3the policy must provide accommodations for patients with disabilities who are subject to 
4pill count requirements.  For the purposes of this subsection, "health care entity" has the 
5same meaning as in Title 22, section 1718-B, subsection 1, paragraph B.
6Sec. 5.  32 MRSA §18308, sub-§6, as enacted by PL 2017, c. 186, §5, is amended 
7to read:
86.  Opioid medication policy.  No later than January 1, 2018, a A health care entity 
9that includes an individual licensed under this chapter whose scope of practice includes 
10prescribing opioid medication must have in place an opioid medication prescribing policy 
11that applies to all prescribers of opioid medications employed by the entity.  The policy 
12must include, but is not limited to, procedures and practices related to risk assessment, 
13informed consent and counseling on the risk of opioid use.  Procedures established under 
14the policy must provide accommodations for patients with disabilities who are subject to 
15pill count requirements.  For the purposes of this subsection, "health care entity" has the 
16same meaning as in Title 22, section 1718-B, subsection 1, paragraph B.
17SUMMARY
18This bill requires that procedures established pursuant to opioid medication policies 
19adopted by health care entities provide accommodations for patients with disabilities who 
20are subject to pill count requirements.
